Guggenheim Capital’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-821
Closed -$267K 1934
2022
Q3
$267K Sell
821
-44
-5% -$14.3K ﹤0.01% 1699
2022
Q2
$228K Sell
865
-77
-8% -$20.3K ﹤0.01% 1893
2022
Q1
$283K Buy
942
+49
+5% +$14.7K ﹤0.01% 1909
2021
Q4
$315K Buy
893
+28
+3% +$9.88K ﹤0.01% 1846
2021
Q3
$221K Sell
865
-20
-2% -$5.11K ﹤0.01% 2027
2021
Q2
$589K Buy
885
+40
+5% +$26.6K ﹤0.01% 1767
2021
Q1
$733K Buy
845
+403
+91% +$350K ﹤0.01% 1531
2020
Q4
$410K Sell
442
-1,721
-80% -$1.6M ﹤0.01% 1709
2020
Q3
$2.22M Sell
2,163
-596
-22% -$613K 0.02% 844
2020
Q2
$2.8M Buy
2,759
+505
+22% +$512K 0.02% 735
2020
Q1
$1.96M Sell
2,254
-442
-16% -$384K 0.02% 795
2019
Q4
$2.89M Buy
2,696
+241
+10% +$258K 0.02% 888
2019
Q3
$2.27M Sell
2,455
-51
-2% -$47.2K 0.02% 959
2019
Q2
$2.83M Buy
2,506
+9
+0.4% +$10.2K 0.02% 899
2019
Q1
$3.39M Sell
2,497
-78
-3% -$106K 0.03% 822
2018
Q4
$2.98M Sell
2,575
-365
-12% -$422K 0.03% 831
2018
Q3
$4.47M Buy
2,940
+80
+3% +$121K 0.03% 782
2018
Q2
$4.48M Sell
2,860
-122
-4% -$191K 0.03% 791
2018
Q1
$3.44M Sell
2,982
-270
-8% -$312K 0.01% 1245
2017
Q4
$3.85M Buy
3,252
+2,861
+732% +$3.39M 0.01% 1186
2017
Q3
$524K Buy
+391
New +$524K ﹤0.01% 2371